Co-founded by a team of doctors and computer scientists out of Harvard Innovation Labs, Buoy Health has grown its overall financing to $66.5m.

Partly based on University of Bern research, Synendos aims to restore the endocannabinoid system to treat dysfunction in the central nervous system.

The healthcare navigation software provider closed a $37.5m round co-led by Cigna Ventures and Humana and backed by Optum Ventures.

Mitsui Fudosan has come onboard as the open banking software producer secured funds that will support global growth and product development.

Sinopharm Capital and the WuXi AppTec-backed 6 Dimensions Capital are among the investors in the inflammatory and autoimmune disease drug developer.

The round included Jubilant Biosys, an existing investor in the liver disease drug startup as well as its contract research organisation partner.

Cisco Investments and Google have both made early-stage bets on Isovalent, a developer of cloud networking management and security tools.

Advancing research from University of Pennsylvania, Kira was formed three years ago and made its public debut yesterday with $46m in funding.

Neuros Medical, a Case Western Reserve University spinout, has raised $69.8m since it was founded in 2008.

Boston Scientific-backed pain relief implant developer Neuros has now raised about $70m in total and is targeting $42.8m in its latest round.